China Pharmaceuticals and Healthcare Report Q4 2009

Executive Summary .7
SWOT Analysis8
China Pharmaceuticals And Healthcare Industry SWOT . 8
China Political SWOT 9
China Economic SWOT .. 10
China Business Environment SWOT. 11
Pharmaceutical Business Environment Ratings .12
Table: Asia Pacific Pharmaceuticals & Healthcare Business Environment Ratings For Q409 12
Limits of Potential Returns 13
Risks to Realisation of Returns 13
Market Summary .14
Regulatory Regime.15
Intellectual Property Issues .. 15
Counterfeit Activities 17
Pricing and Reimbursement.. 18
Advertising Sector.. 20
SFDA Scandal.. 21
Other Regulatory Developments . 22
Industry Trends and Developments.24
Healthcare Sector .. 24
Hospital Sector 26
Top Ten Multinationals Operating In China According To 2008 Hospital Sales. 27
Top Ten Medicines In China According To 2008 Hospital Sales. 28
China’s Hospital Pharmaceutical Market According To Source Of Medicines 28
Epidemiology 29
Traditional Chinese Medicines 33
R&D Activity. 33
Vaccine Sector . 35
Clinical Trials Activity. 37
Biotechnology Sector 38
Active Pharmaceutical Ingredients (APIs). 39
Pharmaceutical Equipment Sector. 40
Industry Forecast Scenario 42
Overall Market Forecast. 42
Table: China – Drug Market Data And Forecasts, 2004-2018 44
Table: Macroeconomic Indicators Used In BMI’s Pharmaceutical Market Expenditure Model, 2003-2013 45
Key Growth Factors – Industry 46
Table: China – Health Expenditure Data And Forecasts, 2003-2013 47
Key Growth Factors – Macroeconomic .. 48
Table: China – Economic Activity, 2006-2013 50
Prescription Drug Market Forecast.. 51
Table: China – Prescription Drug Market Data And Forecasts (CNYmn unless otherwise stated) 52
OTC Medicine Market Forecast . 54
Table: Top Five OTC Medicines In China According To 2008 Sales 55
Table: China – OTC Market Data And Forecasts, 2004-2018 (US$mn unless otherwise stated) 56
Patented Product Market Forecast 57
Table: China Patented Product Market Forecast .. 57
Generic Drug Market Forecast 58
Table: China’s Generic Drug Market Forecast 2004-2018.. 59
Pharmaceutical Trade Forecast . 60
Table: China – Pharmaceutical Trade Data And Forecasts, 2003-2013 (US$mn) . 61
Medical Device Market Forecast 62
China: Medical Device Market Data And Forecasts, 2003-2013 (US$bn unless otherwise stated) 64
Other Healthcare Data Forecasts.. 65
Table: China – Hospital Data Forecasts, 2005-2013 .. 65
Key Risks to BMI’s Forecast Scenario. 66
Competitive Landscape..67
Table: Top 20 Pharmaceutical Companies In China According To 2008 Sales 68
Distribution Sector. 69
China Pharmaceutical Market According To Sales Channel 70
Company Profiles71
Leading Multinational Companies 71
GlaxoSmithKline. 71
Pfizer 73
AstraZeneca.. 75
Merck KGaA. 78
Sanofi-Aventis.. 80
Novartis .. 82
Roche 85
Merck & Co .. 87
Bayer Schering Pharma.. 89
Indigenous Manufacturers 92
North China Pharmaceutical Group Corporation (NCPC) .. 92
China Biopharmaceuticals Holdings (CBH). 94
Hubei Biocause Heilen Pharmaceutical . 96
Aida Pharmaceutical Holdings 98
Country Snapshot: China Demographic Data.100
Section 1: Population. 100
Table: Demographic Indicators, 2005-2030.. 100
Table: Rural/Urban Breakdown, 2005-2030 . 101
Section 2: Education and Healthcare 101
Table: Education, 2002-2005 101
Table: Vital Statistics, 2005-2030 101
BMI Methodology .102
How We Generate Our Pharmaceutical Industry Forecasts . 102
Pharmaceutical Business Environment Ratings Methodology . 103
Ratings Overview. 103
Table: Pharmaceutical Business Environment Indicators .. 104
Weighting. 105
Table: Weighting Of Components 105
Sources 105